Randomised Phase II study comparing alternating cycles of sunitinib and everolimus vs standard sequential administration in first-line metastatic renal carcinoma (SUNRISES study)

Autor: Rodriguez-Vida, A. Bamias, A. Esteban, E. Saez, M.I. Lopez-Brea, M. Castellano, D. Caballero, C. Gonzalez-Larriba, J.L. Calvo, E. Macia, S. Ravaud, A. Bellmunt, J.

Objective: To investigate the efficacy of alternating cycles of sunitinib and everolimus vs standard sequential treatment of sunitinib followed by everolimus in first-line metastatic renal cell carcinoma (mRCC), as alternating blockade of vascular en

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::aab97fc7a559f97e4ce52ea15a61d05b
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3120590

The Challenge of Managing Bladder Cancer and Upper Tract Urothelial Carcinoma: A Review with Treatment Recommendations from the Spanish Oncology Genitourinary Group (SOGUG)

Autor: Font, A, Luque, R, Villa, JC, Domenech, M, Vazquez, S, Gallardo, E, Virizuela, JA, Beato, C, Morales-Barrera, R, Gelabert, A, Macia, S, Puente, J, Rubio, G, Maldonado, X, Perez-Valderrama, B, Pinto, A, Calvo, OF, Grande, E, Garde-Noguera, J, Fernandez-Parra, E, Arranz, JA

Publikováno v: TARGETED ONCOLOGY
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Targeted Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol

Bladder cancer is the fourth most common cancer in men and the ninth most common in women in the Western world. The management of bladder carcinoma requires a multidisciplinary approach. Optimal treatment depends on several factors, including histolo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::23318baf10540f9d531342f54b2480f3
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=8426

Quantification of circulating endothelial cells as a predictor of response to chemotherapy with platinum and pemetrexed in patients with advanced non-squamous non-small cell lung carcinoma

Autor: Hernandez A, Juan O, Martinez J, Blanco R, Macia S, Galiana G, Aparisi F, Noguera J, Catot S, Gaspa F, Garcia-Pinon F

Publikováno v: CLINICAL & TRANSLATIONAL ONCOLOGY
r-FISABIO. Repositorio Institucional de Producción Científica
instname

Circulating endothelial cells (CEC) play an important role in tumor neovascularization and may have prognostic value in cancer patients. This study was designed to investigate the role of CEC as a marker for predicting platinum plus pemetrexed first-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::4a9ae9ed5ea8277e161505620750d88a
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=8427

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.